Explore top 10 tips to secure your open-source projects now. Read More
×
LinuxSecurity Contributor - LinuxSecurity Advisories
Articles From LinuxSecurity Advisories
1 - 2 min read
SUSE: Kernel-Livepatch Important Issues CVE-2025-38617 2025:20947-1
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE Linux Micro: Important Fix for CVE-2025-38664 Kernel-Livepatch
* bsc#1248631 Cross-References: * CVE-2025-38664
1 - 2 min read
SUSE Linux Micro 6.0: kernel-livepatch-MICRO Important Fix 2025:20949-1
* bsc#1248631 * bsc#1249207 Cross-References: * CVE-2025-38618
1 - 3 min read
SUSE: kernel-livepatch-MICRO CVE-2024-53164 Denial of Service Alert
* bsc#1246019 * bsc#1248631 * bsc#1249207 * bsc#1249208
1 - 2 min read
SUSE: Critical Kernel Livepatch Updates for CVEs 2025-38617, 38618, 38664
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE: kernel-livepatch-MICRO Critical Kernel Patch for CVE-2025-38617
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE: Important Kernel Livepatch Issues CVE-2025-38617 to 38664 Advisory
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE: Kernel Livepatch Critical Null Pointer Vulnerability CVE-2025-38664
* bsc#1248631 Cross-References: * CVE-2025-38664
1 - 2 min read
SUSE: Kernel Livepatch Important Network Issue Sec Fix 2025:20955-1
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE: Kernel-Livepatch Important Network Issues CVE-2025-38617 2025:20956-1
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE Linux Micro: Kernel Livepatch Important Update 2025:20957-1
* bsc#1248631 * bsc#1249207 * bsc#1249208 Cross-References:
1 - 2 min read
SUSE: kernel-livepatch-MICRO Important Issues CVE-2025-38664 2025:20958-1
* bsc#1248631 * bsc#1249534 Cross-References: * CVE-2025-38664
Powered By
Linux Security - Your source for Top Linux News, Advisories, HOWTOs and Feature Releases
QUICK LINKS
subscribe to newsletters!
Like staying secure? So do we.
Sign up for updates, tips, and alerts!